Skip to main content

Published locations for More frequent secukinumab dosing found to benefit overweight psoriasis patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. More frequent secukinumab dosing found to benefit overweight psoriasis patients

User login

  • Reset your password
  • /content/more-frequent-secukinumab-dosing-found-benefit-overweight-psoriasis-patients
  • /edermatologynews/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit-overweight
  • /familypracticenews/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit
  • /internalmedicinenews/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit
  • /rheumatologynews/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit-overweight
  • /clinicalendocrinologynews/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit
  • /endocrinology/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit-overweight
  • /rheumatology/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit-overweight
  • /internalmedicine/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit-overweight
  • /dermatology/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit-overweight
  • /familymedicine/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit-overweight
  • /psoriatic-arthritis-icymi/article/251179/psoriasis/more-frequent-secukinumab-dosing-found-benefit